Cargando…
Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
The paradigm of chronic liver diseases has been shifting. Although hepatitis B and C viral infections are still the main causes of liver cirrhosis and hepatocellular carcinoma (HCC), the introduction of effective antiviral drugs may control or cure them in the near future. In contrast, the burden of...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Yeungnam University College of Medicine
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784634/ https://www.ncbi.nlm.nih.gov/pubmed/31620616 http://dx.doi.org/10.12701/yujm.2019.00171 |